Prudence Asset Management Ltd BTAI Holdings History
Prudence Asset Management Ltd's BioXcel Therapeutics Inc Holding Summary
As of 2018-09-30, Prudence Asset Management Ltd held - shares of BioXcel Therapeutics Inc(BTAI), totaling N/A. This investment constitutes 0% of their stock portfolio, and Prudence Asset Management Ltd now holds 0% of the outstanding BioXcel Therapeutics Inc(BTAI) stock.
The initial trade took place in 2018Q2. In addition, there have been 1 sales at an average price of $148.48 for 1,875.00 shares. Based on historical transaction data and BTAI's current price of $1.91, Prudence Asset Management Ltd's estimated gain on his BTAI holdings is $-7,762.50, reflecting a -2.71% gain to date.
Prudence Asset Management Ltd BTAI ($1.91) Holding Chart
Prudence Asset Management Ltd BTAI ($1.91) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
